Navigation Links
Researchers Successfully Test Ebola Vaccines
Date:3/31/2008

Work in primates points to possible weapon against human infection with deadly disease

MONDAY, March 31 (HealthDay News) -- Researchers have successfully tested several Ebola vaccines in monkeys and are now working to create the first human vaccine for one of the world's deadliest diseases.

"The biothreat posed by Ebola virus cannot be overlooked. We are seeing more and more naturally occurring human outbreaks of this deadly disease. With worldwide air travel and tourism, the virus can now be transported to and from remote regions of the world. And it has huge potential as a possible weapon of bioterrorism. We desperately need a protective vaccine," Dr. Anthony Sanchez, of the U.S. Centers for Disease Control and Prevention, said in a prepared statement.

He noted that it has been difficult to create a vaccine for Ebola, "because simple 'killed' viruses that just trigger an antibody response from the blood are not effective. For these viruses, we need to get a cell-mediated response, which involves our bodies producing killer T-cells before immunity is strong enough to prevent or clear an infection."

The team of American and Canadian scientists used several different recombinant DNA techniques to trigger a cell-mediated response and produce Ebola vaccines that are effective in monkeys. One of these vaccines will soon be tested on humans for the first time.

"Ebola virus infection of humans can be highly lethal, but monkeys rarely survive the infection and have been very useful as animal models. Ebola vaccine trials using primates have provided unambiguous results and have allowed the development of protective vaccines to progress rapidly," Sanchez said. "Successful human trials will mean that we can vaccinate health care workers and other key personnel during outbreaks of Ebola hemorrhagic fever, helping us to protect their lives and control the spread of the disease."

The research was to be presented Monday at a meeting of the Society for General Microbiology in Edinburgh, Scotland.

More information

For more on Ebola, visit the U.S. Centers for Disease Control and Prevention.



-- Robert Preidt



SOURCE: Society for General Microbiology, news release, March 30, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researchers identify a gene responsible for cases of Lou Gehrigs disease
2. Researchers identify a gene responsible for Lou Gehrigs disease
3. UCLA researchers examine human embryonic stem cell genome
4. Researchers Create Protective Sac for Growing Stem Cells
5. UC Irvine researchers present latest findings at emergency medicine forum
6. Researchers urge ethics guidelines for human-genome research
7. OHSU Cancer Institute researchers identify new approach to help control drug resistance in leukemia
8. NYU dental researchers find evidence of periodontal disease leading to gestational diabetes
9. Researchers Gain Insights Into On-Off Switch for Cells
10. Molecular science could further improve leukemia survival, say St. Jude researchers
11. Stanford researchers unmask proteins in telomerase, a substance that enables cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers Successfully Test Ebola Vaccines
(Date:4/29/2016)... Newport Beach, Calif. (PRWEB) , ... April 29, 2016 , ... ... affect us. An effective way to confront and deal with these stressors is to ... taste bad to be good for you. Risa Groux, a certified Holistic Nutritionist and ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... more flexibility in repaying their loans, more information about their loan terms and ... total outstanding student loan debt, including federal and private loans, has reached $1.3 ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Spine Team ... pain, is proud to announce one of their physicians has been invited to be ... Physicians (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. ...
(Date:4/29/2016)... ON (PRWEB) , ... April 29, 2016 , ... ... and the Canadian Celiac Association (CCA), is pleased to announce the launch of ... gluten-free products, nutritional articles, recipes, and more. The purpose of the GFCP ...
(Date:4/29/2016)... ... , ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a ... throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , ... patented safety device secured by nasal surgeons onto the floor of the nasal passages, ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... , April 28, 2016 ... "Global Plastic Surgery Products Market 2016-2020" report ... ) , The global plastic surgery ... of 9.47% during the period 2016-2020. , ,The growing ... leading to the growth of the market. Lasers are ...
(Date:4/28/2016)... 28, 2016 Treato , ... healthcare, announced today that it has been named a ... Vendor in Life Sciences, 2016, Stephen Davies ... report focuses on life-science- oriented analytics, algorithms and smart ... and doctors, confirm medication ingestion, and analyze unstructured information. ...
Breaking Medicine Technology: